Namrata Sultania

Associate Vice President

Meet Namrata

Namrata is an Associate Vice President in the Transaction Advisory Services practice at Windy Street, bringing over eight years of experience in audit and financial due diligence across multiple sectors. She has successfully led end-to-end deal executions with a strong focus on the manufacturing, SaaS, IT, and gaming industries. Her expertise spans financial statement analysis, evaluation of deal risks, and in-depth assessment of key financial metrics such as Quality of Earnings (QoE) and working capital. 

Before joining Windy Street in 2025, Namrata worked with the Indian offices of Big Four firms, where she managed several high-profile buy-side and sell-side transactions. Earlier in her career, she was part of statutory audit teams handling listed and privately held companies in India. 

Namrata is a Chartered Accountant and a Chartered Financial Analyst (CFA), with a commerce degree from Osmania University. Outside of work, she enjoys reading and spending her leisure time playing board games. 

Key Highlights

8+

years of experience​

Prior association​

CA

Qualification

FDD

with specialization in manufacturing, SaaS, IT, and gaming sectors.

Let’s Start A Conversation

Windy Street provides expert accounting and advisory services to global firms and businesses, with a strong focus on quality and efficiency.

Contact details

Windy Street, 17th Floor, M3M Urbana Premium Business Park, Sector – 67, Gurgaon, Haryana, Pincode- 122102

connect@windystreet.in

Signup For Our Monthly Newsletter

    Follow us on

    ©2025 Windy Street | All Rights Reserved Privacy Policy Terms & Conditions Cookie PolicySite map Powered by Crongenix

    “Windy Street” or “Windy” is the brand name under which Windy Street Advisory LLP provide professional services. Windy Street Advisory LLP is an entity set-up in India and is not a licensed CPA firm. Our use of the terms “our firm” and “we” and “us” and terms of similar import, represents Windy Street.

    Powered by Crongenix.